Phase I trial to assess the effects of RQ 00000010 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2013
At a glance
- Drugs RQ 00000010 (Primary)
- Indications Constipation; Dyspepsia; Gastrointestinal disorders
- Focus Adverse reactions
- 05 Jun 2013 Positive top-line results reported in a RaQualia media release.
- 05 Jun 2013 The summary of the clinical trial report has been submitted to the MHRA, according to a RaQualia media release.
- 06 Nov 2012 Full results will reported in the first quarter of 2013, according to a RaQualia Pharma media release.